August 1, 2024

Petoskey man is first in state to receive HEMGENIX gene therapy — 9&10 News

GREEN BAY, WI — Andrew Bartkowiak, a Hemophilia Outreach Center patient from Petoskey, became the first Michigan resident with hemophilia B to receive FDA-approved HEMGENIX gene therapy. His treatment offers new hope for fewer bleeds and freedom from regular infusions.

Read full story on 9&10 News

Recent Posts

Building Stronger HTCs for Better Patient Care with Angela Blue

Today on Beyond the Bleeds, Heather and guest co-host Erica are joined by Angela Blue, Director of Member & Community Relations with the Hemophilia Alliance, for a conversation about the important work happening behind the scenes to support Hemophilia Treatment...

The Evolution of Hemophilia Treatment with Dr. Ken Friedman

Today on Beyond the Bleeds, Heather and John are joined by Dr. Ken Friedman from Versiti Blood Center and HOC for a conversation about the evolution of hemophilia treatment. Drawing on decades of experience in hematology and bleeding disorders care, Dr. Friedman...

Out On The Town: Bleeding Disorders Awareness Edition

In this special episode of Beyond the Bleeds, Heather and John take bleeding disorder awareness beyond the clinic and into the community. From downtown Green Bay to St. Norbert College in De Pere, Wisconsin, they hit the streets to ask everyday people what they know...

Social Media